Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Gries

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacology|October 15, 2021
Off-Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk-Benefit ProfileSudhakar M Pai, Jean-Michel Gries,
Journal of Clinical Pharmacology|October 4, 2023
ACCP Position Statement on Hydration and Vitamin Infusion ClinicsPeter L Bonate, Alexander J Prokopienko, Jean-Michel Gries, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gumMaria Pitsiu, Jean-Michel Gries, Neal Benowitz, et al.
Journal of Clinical Pharmacology|November 25, 2024
Sentinel Dosing-Time for a Risk-Based Approach?Peter L Bonate, Mark Rogge, Jean-Michel Gries, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2003
Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridolPeter J Nelson, Vivette D D'Agati, Jean-Michel Gries, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapyMark Sulkowski, Teresa Wright, Stephen Rossi, et al.
Mabs|March 7, 2023
Blueprint for antibody biologics developabilityCarl Mieczkowski, Xuejin Zhang, Dana Lee, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 13, 2006
Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis CKathleen B Schwarz, Parvathi Mohan, Michael R Narkewicz, et al.
Journal of Clinical Pharmacology|December 4, 2020
Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDASudhakar M Pai, Ahmed A Othman, Lorraine Rusch, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacology|October 15, 2021
Off-Label Use of Ketamine: A Challenging Drug Treatment Delivery Model With an Inherently Unfavorable Risk-Benefit ProfileSudhakar M Pai, Jean-Michel Gries,
Journal of Clinical Pharmacology|October 4, 2023
ACCP Position Statement on Hydration and Vitamin Infusion ClinicsPeter L Bonate, Alexander J Prokopienko, Jean-Michel Gries, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gumMaria Pitsiu, Jean-Michel Gries, Neal Benowitz, et al.
Journal of Clinical Pharmacology|November 25, 2024
Sentinel Dosing-Time for a Risk-Based Approach?Peter L Bonate, Mark Rogge, Jean-Michel Gries, et al.
The Journal of Antimicrobial Chemotherapy|March 26, 2003
Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridolPeter J Nelson, Vivette D D'Agati, Jean-Michel Gries, et al.
Clinical Pharmacology and Therapeutics|March 1, 2005
Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapyMark Sulkowski, Teresa Wright, Stephen Rossi, et al.
Mabs|March 7, 2023
Blueprint for antibody biologics developabilityCarl Mieczkowski, Xuejin Zhang, Dana Lee, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 13, 2006
Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis CKathleen B Schwarz, Parvathi Mohan, Michael R Narkewicz, et al.
Journal of Clinical Pharmacology|December 4, 2020
Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDASudhakar M Pai, Ahmed A Othman, Lorraine Rusch, et al.
Pageof 1